Late-Breaking Data at IMDX Sets New Bar for Graft Rejection Prediction in Kidney Transplants
Insight Molecular Diagnostics (IMDX) has unveiled compelling data at the World Transplant Congress, showcasing a novel approach to quantifying...
Insight Molecular Diagnostics (IMDX) has unveiled compelling data at the World Transplant Congress, showcasing a novel approach to quantifying...
Sirona Biochem, a cosmetic ingredient and drug discovery company, is facing significant financial distress, culminating in the liquidation of...
Roche’s Susvimo secures five-year efficacy and safety data in neovascular age-related macular degeneration (nAMD), potentially reshaping the treatment landscape...
Artelo Biosciences has secured positive scientific advice from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its...
Orchestra Biomed Secures $70M in Strategic Funding, Signaling Growing Confidence in Late-Stage Cardiology Programs Orchestra Biomed has secured $70...
Liminatus Pharma, a preclinical biopharmaceutical company, is making a striking move into the cryptocurrency market, planning to acquire up...
Bio Usawa and DEK Forge Partnership to Tackle Africa’s Growing Non-Communicable Disease Burden Bio Usawa, a private biotech company...
Branded Legacy, Inc., a diversified holdings company, is poised to enter the burgeoning naloxone and vaccine markets through a...
Vivex Biologics has completed patient enrollment in its ASCEND trial, a pivotal study evaluating VIA Disc NP, a novel...
EyePoint Pharmaceuticals has achieved full enrollment in its LUCIA trial, the second of two pivotal Phase 3 studies evaluating...